Papers
31
Total Citations
1,709
H-Index
20
About
Jonas Hugosson is a leading urologic oncologist whose research has fundamentally shaped the surgical management of prostate cancer. His primary contributions lie in high-impact, prospective comparative effectiveness research, most notably through his leadership of the landmark LAPPRO trial. This comprehensive study directly compared robot-assisted laparoscopic radical prostatectomy (RALP) with the traditional open retropubic approach, providing crucial evidence on functional and oncologic outcomes. Hugosson’s work has clarified key trade-offs, demonstrating that while RALP may offer advantages in reducing blood loss and hospital stay, it does not uniformly surpass open surgery for long-term urinary continence and erectile function, with his 2015 study on incontinence and erectile dysfunction accumulating nearly 500 citations. His research also rigorously examined the degree of nerve-sparing necessary for preserving urinary control and the health economic implications of adopting costly robotic technology. By generating high-quality, prospective data through the LAPPRO trial, Hugosson has provided the urologic community with the evidence needed to guide surgical decision-making, moving the field beyond anecdotal claims toward data-driven patient counseling and policy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10